Table 2 Clinical characteristics.

From: Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study

Clinical characteristic

Total (N = 50)

Age at diagnosis, median (range), years

26 (16–52)

Time since diagnosis, median (range), years

15 (2–42)

Screening assessment

 MAP-SR, mean (SD)

14.9 (8.9)

Baseline assessments

 CAINS-MAP, mean (SD)

20.5 (8.3)

 PSP1, mean (SD)

54.3 (12.9)

Number of concomitant antipsychotic medications used2

 Diazepines, oxazepines, thiazepines, and oxepines

31

 Other antipsychotics

18

 Indole derivatives

7

  1. CAINS-MAP clinical assessment interview for negative symptoms motivation and pleasure subscale, MAP-SR motivation and pleasure scale—self report, PSP personal and social performance, SD standard deviation.
  2. 1Adjusted using clinical judgment.
  3. 2Concomitant use of antipsychotics was reported by all 50 participants (n = 44 receiving 1 antipsychotic; n = 6 receiving 2 antipsychotics).
Back to article page